logo
logo
Sign in

Exploration of Anti-infective Drug Development: Challenges and Emerging Opportunities

avatar
Adi Intellect
Exploration of Anti-infective Drug Development: Challenges and Emerging Opportunities

Anti-infectives are the agents or drugs that help to eradicate the infection from the human body.

As the infectious diseases like dengue fever, Ebola infection, tuberculosis, bacterial meningitis, malaria, etc., are rising at a high pace, the development of new anti-infective agents has become a global health priority.

However, the primary challenge that cannot be ignored is that the anti-infective agents are considered less profitable than other drugs.

This is because the infectious agents become resistant to the treatment very soon, making it ineffective and leads to their short-term use.

Thus, doctors avoid prescribing newly developed drugs and keep them reserved until older drugs fail.

But, as per the tight enrolment criteria in clinical studies, the pregnant population is mostly avoided for the enrolment due to the ethical concerns and health risks of the drug on pregnancy outcome and developing a fetus.

collect
0
avatar
Adi Intellect
guide
Zupyak is the world’s largest content marketing community, with over 400 000 members and 3 million articles. Explore and get your content discovered.
Read more